Oncolytics Biotech

ONCYNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$95.782 M

$0.80 +0.24%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$28.8M

Loss-making

Shares outstanding

116,128,162

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#305RafaelRFL$106.6M
#306Rani TherapeuticsRANI$98.1M
#307Oncolytics BiotechONCY$95.8M
#308Aldeyra TherapeuticsALDX$93.5M
#309Heron TherapeuticsHRTX$92.9M

Where these numbers come from

Share counts and financials for Oncolytics Biotech are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.